Rethinking Mandatory HIV Testing During Pregnancy in Areas With High HIV Prevalence Rates
Ethical and Policy Issues
Bibliographic Data
We analyzed the ethical and policy issues surrounding mandatory HIV testing of pregnant women in areas with high HIV prevalence rates. Through this analysis, we seek to demonstrate that a mandatory approach to testing and treatment has the potential to significantly reduce perinatal transmission of HIV and defend the view that mandatory testing is morally required if a number of conditions can be met. If such programs are to be introduced, continuing medical care, including highly active antiretroviral therapy, must be provided and pregnant women must have reasonable alternatives to compulsory testing and treatment. We propose that a liberal regime entailing abortion rights up to the point of fetal viability would satisfy these requirements. Pilot studies in the high-prevalence region of southern African countries should investigate the feasibility of this approach
Abortion · Antiretroviral therapy · Engineering ethics · Environmental health · Ethical issues · Family medicine · HIV screening · Human immunodeficiency virus (HIV) · Pregnancy · Viral load · Global Maternal and Child Health · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine
Mandatory Hiv Testing in Pregnancy
What Is a Human-Rights Based Approach to Health and Does It Matter
Aids – the time for changes in law and policy is now
The complexity of consent
Questioning Mandatory Hiv Testing During Pregnancy
Stigma, Structural Vulnerability, and “What Matters Most” Among Women Living With HIV in Botswana, 2017
Stigma, HIV/Aids and prevention of mother-to-child transmission in Zambia
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
Shadow on the continent
Mother-to-Child Transmission of Hiv in Botswana
How stigmatizing is Stigma in the life of people living with HIV
Misguided Retribution
The Moral Significance of Birth
Contesting Motherhood in the Age of Aids
| Citations per year | 0.33 |
|---|---|
| Citation span | 2008 - 2021 (14) |
| Highly cited | No |